{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/ll-37.json","peptide":{"slug":"ll-37","name":"LL-37","url":"https://peptidescanner.com/peptides/ll-37/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":31,"entries":[{"objectId":"story:clinicaltrials-gov-nct02225366-ll-37:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02225366","domain":"Clinical trials","dateInSource":"2021-12-09","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02225366-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#clinicaltrials-gov-nct02225366-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#clinicaltrials-gov-nct02225366-ll-37-v1","contentSha256":"80cd2eebe070dd873c22b126595af57073f20461b2852d0e6e25d9392e590f13"},{"objectId":"story:pubmed-pmid-23931055-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Defensins and LL-37: a review of function in the gingival epithelium.","domain":"Literature metadata","dateInSource":"2024-05-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23931055-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-23931055-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-23931055-ll-37-v1","contentSha256":"af994341daa9a24d59f70bf5847d6f76b2d95f7efbf8462c33b24d2c8288bb60"},{"objectId":"story:pubmed-pmid-24463069-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24463069-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-24463069-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-24463069-ll-37-v1","contentSha256":"b366df48dd8c98d92529acbfb8d5498e85c3f8960070b1c10dee07050e4d7fe1"},{"objectId":"story:pubmed-pmid-24738326-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"[A review: the role of antimicrobial peptide LL-37 in chronic sinusitis].","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24738326-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-24738326-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-24738326-ll-37-v1","contentSha256":"0d1060294f6c573d2a6bd1e5723c337821fe31bb9396f1ecdfbb4cf873a059cd"},{"objectId":"story:pubmed-pmid-25101632-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-25101632-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-25101632-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-25101632-ll-37-v1","contentSha256":"a93761547f513675210464076eff78c3430007f6fb03cc4fdffcd85ebe578d72"},{"objectId":"story:pubmed-pmid-26395996-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"The Role of Cathelicidin LL-37 in Cancer Development.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26395996-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-26395996-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-26395996-ll-37-v1","contentSha256":"d0c2ec029438c3ae5f0a0a6f6afdde349f649fcbc2e00b01156255310ba4653e"},{"objectId":"story:pubmed-pmid-26434733-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Unique features of human cathelicidin LL-37.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26434733-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-26434733-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-26434733-ll-37-v1","contentSha256":"ad220e1f4c77fe30c1f8f9b80bc625974af39bbb8c74ca95e7724f8e93e0b227"},{"objectId":"story:pubmed-pmid-27117377-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27117377-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-27117377-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-27117377-ll-37-v1","contentSha256":"7e9478f4903688c17cda610987f55937bdb81c8b9c2c4614759aef1021ffb000"},{"objectId":"story:pubmed-pmid-27135484-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27135484-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-27135484-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-27135484-ll-37-v1","contentSha256":"aa03eb133189b40e281be755640e6bb9a522602615c8839cda1a3cf8244484d5"},{"objectId":"story:pubmed-pmid-28218580-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28218580-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-28218580-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-28218580-ll-37-v1","contentSha256":"3653f01870e8deee3d9d7495a95355b2a842226cb747da4de4068a1893ae873c"},{"objectId":"story:pubmed-pmid-28956425-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28956425-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-28956425-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-28956425-ll-37-v1","contentSha256":"5cd74328687f48d90554665073c9ee62d6cfdb6c86ca0bf683e2938cce5e0f6f"},{"objectId":"story:pubmed-pmid-29843147-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29843147-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-29843147-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-29843147-ll-37-v1","contentSha256":"913ade6793d09d02f842fed7639eb3b3c746a79227984d871c2e9f702755275b"},{"objectId":"story:pubmed-pmid-30980360-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30980360-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-30980360-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-30980360-ll-37-v1","contentSha256":"20de9e2a04d2333dd972c1725d730fa235da2f359ef3120999c46328175b675a"},{"objectId":"story:pubmed-pmid-31687504-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells.","domain":"Literature metadata","dateInSource":"2024-07-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-31687504-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-31687504-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-31687504-ll-37-v1","contentSha256":"3b24c2daf8c70a98b54262208720375f59a279dde1f1fe8e0421c3191379dcec"},{"objectId":"story:pubmed-pmid-32743514-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus.","domain":"Literature metadata","dateInSource":"2020-09-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32743514-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-32743514-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-32743514-ll-37-v1","contentSha256":"990f283d1cec1b17abbc4034b191e4a6aa7f7a46701a00d12b99f5886300d988"},{"objectId":"story:pubmed-pmid-32927756-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections.","domain":"Literature metadata","dateInSource":"2023-11-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32927756-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-32927756-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-32927756-ll-37-v1","contentSha256":"f4013e8857aeb16c16f00ff23897ea66b184d89d0c4106f36466646ccb44cea6"},{"objectId":"story:pubmed-pmid-34068993-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-34068993-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-34068993-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-34068993-ll-37-v1","contentSha256":"ab63c0dab57c4de904d80261773f6f300d360f4500236125cb3b06f09440dc4e"},{"objectId":"story:pubmed-pmid-36081952-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy.","domain":"Literature metadata","dateInSource":"2022-09-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-36081952-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-36081952-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-36081952-ll-37-v1","contentSha256":"592714b4f16de96df0d506c28400d7ef7446ff66552ec805012ab2b2d68063de"},{"objectId":"story:pubmed-pmid-36781570-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Antibiofilm properties of cathelicidin LL-37: an in-depth review.","domain":"Literature metadata","dateInSource":"2026-10-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-36781570-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-36781570-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-36781570-ll-37-v1","contentSha256":"f748edbbc8d99eb8e2bf7da8ef05c380ef5ecf3c0dd0791cbf62273c1d072ccf"},{"objectId":"story:pubmed-pmid-37919905-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids.","domain":"Literature metadata","dateInSource":"2026-03-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37919905-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-37919905-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-37919905-ll-37-v1","contentSha256":"da8e19c44bfd5c81da4c08a20d640cea0d9fe2f2548a2450bbb65636032b842a"},{"objectId":"story:pubmed-pmid-38057654-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Antifungal properties of cathelicidin LL-37: current knowledge and future research directions.","domain":"Literature metadata","dateInSource":"2026-10-31","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38057654-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-38057654-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-38057654-ll-37-v1","contentSha256":"1678690ccdfdd21b5efe3b8b379f4dda5d145da4f8281c81cf6cb4a18b9e1eda"},{"objectId":"story:pubmed-pmid-38540740-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases.","domain":"Literature metadata","dateInSource":"2026-04-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38540740-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-38540740-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-38540740-ll-37-v1","contentSha256":"294da1e198322cf9ac6f5d15542ecfe5273733879b1f77c0fd33b26f0e4fc5c0"},{"objectId":"story:pubmed-pmid-38604693-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"[Progress of researches on the antiparasitic activity of antimicrobial peptide LL-37].","domain":"Literature metadata","dateInSource":"2024-04-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38604693-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-38604693-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-38604693-ll-37-v1","contentSha256":"bd5b0fe544eedcab1c32c56b5ce7c7bd5fa36dd853eeeb13fa9817526d3933ee"},{"objectId":"story:pubmed-pmid-39615616-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease.","domain":"Literature metadata","dateInSource":"2025-01-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39615616-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-39615616-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-39615616-ll-37-v1","contentSha256":"a00bbdd6baa76a8b362b2cbd2a8b8dd53355fd0fb0c2cafb95561373431e23bc"},{"objectId":"story:pubmed-pmid-39643165-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity.","domain":"Literature metadata","dateInSource":"2025-01-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39643165-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-39643165-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-39643165-ll-37-v1","contentSha256":"932d2512b15775c7cda64d038da64f402f2e8861baffe590db73c102a36a0bae"},{"objectId":"story:pubmed-pmid-39954662-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Cathelicidin LL-37 in periodontitis: current research advances and future prospects - A review.","domain":"Literature metadata","dateInSource":"2025-05-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39954662-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-39954662-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-39954662-ll-37-v1","contentSha256":"a12e489b6e3558b41ac27a0426db79f0c12528bdfa7f11a972d1dbbe3c2bc336"},{"objectId":"story:pubmed-pmid-40869425-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications.","domain":"Literature metadata","dateInSource":"2025-08-31","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-40869425-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-40869425-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-40869425-ll-37-v1","contentSha256":"01fbf2104caf5dbab2701678bb721d091cbbbb128074a38674c63a8cfb9dc37d"},{"objectId":"story:pubmed-pmid-40960088-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis.","domain":"Literature metadata","dateInSource":"2025-09-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-40960088-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-40960088-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-40960088-ll-37-v1","contentSha256":"26694e649226511020a9b38b2477e8d07525d29ee096d4866a27df831b94ebdf"},{"objectId":"story:pubmed-pmid-41270816-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats.","domain":"Literature metadata","dateInSource":"2025-12-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41270816-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-41270816-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-41270816-ll-37-v1","contentSha256":"0faa486e9387392350a41398e5d865521ee39ed3fe4aa2b44f5e139253dce2cd"},{"objectId":"story:pubmed-pmid-42095322-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease.","domain":"Literature metadata","dateInSource":"2026-09-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42095322-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-42095322-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-42095322-ll-37-v1","contentSha256":"08ae3e47f48e5b1a1ba96aee2a03843e82c53690d708b970153e1d6126bead40"},{"objectId":"story:pubmed-pmid-42861262-ll-37:v1","state":"current","stateChangedAt":"2026-11-15","title":"LL-37-MRGPRX2-Mast Cell Signaling in Rosacea: Current Evidence and Directions for Human Studies.","domain":"Literature metadata","dateInSource":"2026-10-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42861262-ll-37/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-42861262-ll-37-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/ll-37.md#pubmed-pmid-42861262-ll-37-v1","contentSha256":"899be6a48275f611b22c3c3a527e75120460d64d38020c5ab8b925ff6029bcc0"}]}
